Literature DB >> 2847979

Opsonization-enhanced phagocytosis of foot-and-mouth disease virus.

K C McCullough1, D Parkinson, J R Crowther.   

Abstract

Using isolated peritoneal adherent cells, in which monocytes and macrophages dominate, the uptake and destruction of foot-and-mouth disease virus (FMDV) was enhanced by the opsonization with mAb of particular epitope specificity. This was seen under conditions in which virus infectivity was not neutralized, as determined by in vitro assay. Activation of macrophages in vivo further enhanced the uptake of opsonized virus, presumably by increasing the percentage of phagocytosing cells. The enhanced phagocytosis required opsonization and apparently made use of FcR+ cells, because pepsin-treated antibodies and separated F(ab')2 fragments did not enhance the capacity of the peritoneal cells to react with the virus. The reaction also relied on active phagocytosis, because inhibition of phagocytosis using silica interfered with the binding of both virus alone and virus/antibody complexes. This evidence shows that the previous in vivo observations (McCullough et al., 1986b) of enhanced protection by the mAb can be related to active phagocytosis of virus and virus/antibody complexes. The reaction is not passive adsorption to the monocyte surface, but an active phagocytosis of the virus or the complex.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2847979      PMCID: PMC1384912     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  8 in total

1.  PURIFICATION OF RADIOACTIVE FOOT-AND-MOUTH DISEASE VIRUS.

Authors:  F BROWN; B CARTWRIGHT
Journal:  Nature       Date:  1963-09-21       Impact factor: 49.962

2.  [Relation between the titer of neutralizing antibodies and the protection of animals following anti-aphthous vaccination].

Authors:  C MACKOWIAK; R LANG; J FONTAINE; R CAMAND; H G PETERMANN
Journal:  Ann Inst Pasteur (Paris)       Date:  1962-08

3.  A liquid-phase ELISA and its use in the identification of epitopes on foot-and-mouth disease virus antigens.

Authors:  K C McCullough; J R Crowther; R N Butcher
Journal:  J Virol Methods       Date:  1985-08       Impact factor: 2.014

4.  Subfragments from the Fc fragment of human immunoglobulin G. Isolation and physicochemical charaterization.

Authors:  M W Turner; H Bennich
Journal:  Biochem J       Date:  1968-03       Impact factor: 3.857

5.  A new enzyme-linked immunosorbent assay (ELISA) for the detection of antibodies against foot-and-mouth disease virus. II. Application.

Authors:  C Hamblin; I T Barnett; J R Crowther
Journal:  J Immunol Methods       Date:  1986-10-23       Impact factor: 2.303

6.  Immune protection against foot-and-mouth disease virus studied using virus-neutralizing and non-neutralizing concentrations of monoclonal antibodies.

Authors:  K C McCullough; J R Crowther; R N Butcher; W C Carpenter; E Brocchi; L Capucci; F De Simone
Journal:  Immunology       Date:  1986-07       Impact factor: 7.397

7.  Monoclonal antibodies against foot-and-mouth disease virus 146S and 12S particles.

Authors:  K C McCullough; R Butcher
Journal:  Arch Virol       Date:  1982       Impact factor: 2.574

8.  Epitopes on foot-and-mouth disease virus particles. I. Topology.

Authors:  K C McCullough; J R Crowther; W C Carpenter; E Brocchi; L Capucci; F De Simone; Q Xie; D McCahon
Journal:  Virology       Date:  1987-04       Impact factor: 3.616

  8 in total
  30 in total

Review 1.  Foot-and-mouth disease.

Authors:  Marvin J Grubman; Barry Baxt
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

2.  Characterization of antibody responses to combinations of a dengue virus type 2 DNA vaccine and two dengue virus type 2 protein vaccines in rhesus macaques.

Authors:  Monika Simmons; Kevin R Porter; Curtis G Hayes; David W Vaughn; Robert Putnak
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

3.  Tumour necrosis factor triggers granulocytes to internalize complement-coated virus particles.

Authors:  J A van Strijp; M E van der Tol; L A Miltenburg; K P van Kessel; J Verhoef
Journal:  Immunology       Date:  1991-05       Impact factor: 7.397

4.  Complement-mediated phagocytosis of herpes simplex virus by granulocytes. Binding or ingestion.

Authors:  J A Van Strijp; K P Van Kessel; M E van der Tol; J Verhoef
Journal:  J Clin Invest       Date:  1989-07       Impact factor: 14.808

5.  Rapeseed oil and ginseng saponins work synergistically to enhance Th1 and Th2 immune responses induced by the foot-and-mouth disease vaccine.

Authors:  Cenrong Zhang; Yuemin Wang; Meng Wang; Xiaoyan Su; Yisong Lu; Fei Su; Songhua Hu
Journal:  Clin Vaccine Immunol       Date:  2014-06-11

6.  Foot-and-mouth disease virus exhibits an altered tropism in the presence of specific immunoglobulins, enabling productive infection and killing of dendritic cells.

Authors:  L Robinson; M Windsor; K McLaughlin; J Hope; T Jackson; B Charleston
Journal:  J Virol       Date:  2010-12-22       Impact factor: 5.103

7.  Dendritic cell internalization of foot-and-mouth disease virus: influence of heparan sulfate binding on virus uptake and induction of the immune response.

Authors:  Lisa J Harwood; Heidi Gerber; Francisco Sobrino; Artur Summerfield; Kenneth C McCullough
Journal:  J Virol       Date:  2008-04-30       Impact factor: 5.103

8.  Enhancement of serological immune responses to foot-and-mouth disease vaccine by a supplement made of extract of cochinchina momordica seeds.

Authors:  Chenwen Xiao; Zahid Iqbal Rajput; Diwen Liu; Songhua Hu
Journal:  Clin Vaccine Immunol       Date:  2007-10-17

Review 9.  Protective immune response against foot-and-mouth disease.

Authors:  K C McCullough; F De Simone; E Brocchi; L Capucci; J R Crowther; U Kihm
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

Review 10.  Antibodies against viruses: passive and active immunization.

Authors:  Mansun Law; Lars Hangartner
Journal:  Curr Opin Immunol       Date:  2008-07-01       Impact factor: 7.486

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.